Abstract
Neural tube defects are congenital structural abnormalities of the brain and vertebral column resulting from improper or non-timely closure of the neural tube. Prevalence of neural tube defects is reported to be higher among women with diabetes mellitus and obesity. This study was designed to investigate the relation between the presence of dyslipidemia in antenatal patients and the risk of fetal neural tube defects. The present study was an observational, cross-sectional study involving 129 pregnant women in 16 to 18 weeks gestation period. Of these, 80 women had normal pregnancies and 49 were clinically high-risk cases for neural tube defects. Fasting blood samples were analyzed for blood sugar and lipid profile by enzymatic assay and alpha-fetoprotein levels using Enzyme Immunoassay. Alpha-fetoprotein (AFP) values were converted to Multiples of Median (MoM) appropriate for the gestational age. Based on AFP values, women were labeled as screen negative (AFP <2 MoM, n= 102) and screen positive (AFP > 2 MoM, n =27). Screen positive women were further evaluated by ultrasound and 21 women were found to carry a neural tube defects positive pregnancy. Statistical analysis was done on SPSS software. Body weight of the women showed a significant positive correlation with serum triglycerides, plasma sugar and AFP MoM values. A significant difference was observed in serum cholesterol levels (p= 0.038), triglycerides (p=0.001) and plasma sugar levels (p=0.002) between normal women and those with neural tube defects positive pregnancy. The Odds ratio for neural tube defects risk in dyslipidemic cases was 24.23 (CI 4.73 − 148.60) with a relative risk of 12.12. Dyslipidemia especially hypertriglyceridemia was found to be significantly associated with fetal neural tube defects.
Similar content being viewed by others
References
Muller F. Prenatal Biochemical Screening for neural tube defects. Child’s Nerv Syst 2003;19(7–8); 433–435.
Verma IC, Mathews AR. Congenital malformations in India. In: Peoples of India: Some Genetical Aspects. Ed. Satyavati GV. New Delhi, Indian Council of Medical Research, 1983; p 70.
Sharma AK, Upreti M, Kamboi M, Mebra P, Das K, Misra A, et al. Incidence of neural tube defects at Lucknow over a 10 years period from 1982–91. Ind J Med Res 1994; 99: 223–226.
Kulkarni ML, Mathew MA, Ramchandran B. High incidence of neural tube defects in South India. Lancet 1987; i: 260.
Kulkarni ML, Mathew MA, Reddy V. The range of neural tube defects in southern India. Arch Dis Child 1989; 64: 201–204.
Johnston MV. Kinsman S. Neural tube defects. In: Behrman RE, Kliegman RM, Jenson HB eds. Nelson Textbook of Pediatrics. 17th Edition. WB Saunders, 2004; 1983–2009.
Sever LE. Looking for causes of neural tube defects: where does the environment fit in? Environ Health Perspect 1995;103Suppl 6:165–171.
Little L, Elwood JM. Epidemiology of neural tube defects. Reproductive and Perinatal Epidemiology. Kiley M, Ed., CRC Press, Boston, 1991, 251–336.
Lemire RJ. Neural tube defects. JAMA 1988; 259:558–562.
Owen TJ, Halliday JL, Stone CA. Neural tube defects in Victoria, Australia: potential contributing factors and public health implications. Aust N Z J Public Health 2000; 24: 584–589.
Hendricks KA, Simpson JS, Larsen RD. Neural tube defects along the Texas-Mexico border, 1993–1995. Am J Epidemiol 1999; 149: 1119–1127.
Ray JG, Wyatt PR, Vermeulen MJ, Meier C, Cole DEC. Greater maternal weight and the Ongoing risk of neural tube defects after folic acid flour fortification. Obstet Gynaecol 2005; 105(2): 261–265.
Feldman B, Yaron Y, Critchfield G, Leon J, O’Brien JE, Johnson MP, Evans MI. Distribution of neural tube defects as a function of maternal weight: No apparent correlation. Fetal Diagn Ther 1999;14: 185–189.
Anderson JL, Waller DK, Canfield MA, Shaw GM, Watkins ML, Werler MM. Maternal obesity, gestational diabetes, and central nervous system birth defects. Obstet Gynecol Surv 2005; 60(6): 341–342.
Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 2001; 61:85–95.
Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000; 71(5): 1256S–1261S.
Canick JA, Saller DN. Maternal serum screening for aneuploidy and open fetal defects. Prenat Diagn 1993; 20: 443–454.
Boyd PA, Wellesley DG, De Walle HE, Tenconi R, Garcia-Minaur S, Zandwijken GR, Stoll C, Clementi M. Evaluation of the prenatal diagnosis of neural tube defects by fetal ultrasonographic examination in different centres across Europe. J Med Screen 2000; 7:169–174.
Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA 1996; 275:1093–1096.
Abrams B, Carmichael S, Selvin S. Factors associated with the pattern of maternal weight gain during pregnancy. Obstet Gynaecol 1995: 86: 170–176.
Assel B, Rossi K, Kalhan S. Glucose metabolism during fasting through human pregnancy: comparison of tracer method with respiratory calorimetry. Am J Physiol 1993; 265:E351–E356.
Kuhl C. Aetiology of gestational diabetes. Baillieres Clin Obstet Gynaecol 1991; 5: 279–292.
Lesser KB, Carpenter MW. Metabolic changes associated with normal pregnancy and pregnancy complicated by diabetes mellitus. Semin Perinatol 1994; 18:399–406.
Halstead AC, Lockitch G, Vallance H, Wadsworth L, Wittmann B. Handbook of diagnostic biochemistry and hematology in normal pregnancy. Boca Raton, FL: CRC Press, 1993: 3–235.
National Institutes of Health: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary. Bethesda, Md.: National Institutes of Health, National Heart Lung and Blood Institute, 2001 (NIH publication no. 01-3670). http://www.nhlbi.nih.gov/guidelines/cholesterol/index.htm.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553.
Ray JG, Thompson MD, Vermeulen MJ, Meier C, Wyatt PR, Wong PY, Summers AM, Farrell SA, Cole DEC. Metabolic Syndrome features and risk of neural tube defects. BMC Pregnancy and Childbirth 2007, 7:21–25.
Jovanovic-Peterson L, Peterson CM. Abnormal Metabolism and risk of birth defects with emphasis on diabetes. Ann NY Acad Sci 1993; 678: 228–243.
Shaw GM, Quach T, Nelson V, Carmichael SL, Schaffer DM, Selvin S, Yang W. Neural Tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr 2003; 78: 972–978.
Knopp RH, Warth MR, Charles D, Childs M, Li JR, Mabuchi H, Van Allen MI. Lipoprotein metabolism in pregnancy, fat transport to the fetus and the effects of diabetes. Biol Neonate 1986; 50(6): 297–317.
Moley KH, Chi MMY, Knudson CM, Korsmeyer SJ, Mueckler MM. Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 1998; 4: 1421–1424.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, S., Arora, S., Trivedi, S.S. et al. Dyslipidemia in pregnancy may contribute to increased risk of neural tube defects -a pilot study in north Indian population. Indian J Clin Biochem 24, 150–154 (2009). https://doi.org/10.1007/s12291-009-0027-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-009-0027-9